CSIMarket Company Name, Ticker, Suppliers, else..
 
Acceleron Pharma inc  (NASDAQ: XLRN)
 

XLRN's Market share relative to its competitors, as of Q3 2021

As of Q3 2021 (Revenue in Millions of $)

Date modified: 2026-05-18T05:11:54+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2021		 MARKET SHARE
12 Months
Q3 2021		 MARKET SHARE
MRQ
Q3 2021		 MARKET SHARE
A Quarter Before
Q2 2021
Acceleron Pharma inc 112.76 26.91% 74.20 % 83.47 %
Keros Therapeutics Inc 265.45 63.35% 0.00% 8.07%
Editas Medicine Inc 38.69 9.23% 25.80% 8.46%
Summit Therapeutics Inc 2.08 0.50% 0.00% 0.00%
Inozyme Pharma Inc 0.00 0.00% 0.00% 0.00%
Trevi Therapeutics Inc 0.00 0.00% 0.00% 0.00%



XLRN's Market share relative to its competitors, as of Q3 2021 within the Biotechnology & Pharmaceuticals Industry
As of Q3 2021



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2021		 MARKET SHARE
12 Months Ending
Q2 2021		 MARKET SHARE
MRQ
Q3 2021		 MARKET SHARE

Q2 2021
Acceleron Pharma inc 74.45% 71.39% 74.20 % 90.80 %
Editas Medicine Inc 25.55% 28.61% 25.80% 9.20%



XLRN's Market share relative to its competitors, as of Q3 2021 within the Healthcare Sector
As of Q3 2021



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2021		 MARKET SHARE
12 Months Ending
Q2 2021		 MARKET SHARE
MRQ
Q3 2021		 MARKET SHARE

Q2 2021
Acceleron Pharma inc 26.91% 24.32% 74.20 % 83.47 %
Keros Therapeutics Inc 63.35% 65.48% 0.00% 8.07%
Editas Medicine Inc 9.23% 9.74% 25.80% 8.46%
Summit Therapeutics Inc 0.50% 0.46% 0.00% 0.00%
Inozyme Pharma Inc 0.00% 0.00% 0.00% 0.00%
Trevi Therapeutics Inc 0.00% 0.00% 0.00% 0.00%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Acceleron Pharma inc's market divisions, geographic dispersion, segments, products, and services, visit Acceleron Pharma inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.